T. Rowe Price Associates
HCA icon

T. Rowe Price Associates’s HCA Healthcare HCA Stock Holding History

T. Rowe Price Associates’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246M Sell
520,317
-41,273
-7% -$20.8M 0.03% 409
2025
Q4 		$262M Buy
561,590
+9,139
+2% +$4.24M 0.03% 388
2025
Q3 		$235M Sell
552,451
-813,787
-60% -$315M 0.03% 421
2025
Q2 		$523M Sell
1,366,238
-1,033,134
-43% -$372M 0.06% 264
2025
Q1 		$829M Buy
2,399,372
+1,091,416
+83% +$351M 0.1% 191
2024
Q4 		$393M Sell
1,307,956
-97,353
-7% -$34M 0.05% 307
2024
Q3 		$571M Sell
1,405,309
-988,580
-41% -$362M 0.07% 259
2024
Q2 		$769M Sell
2,393,889
-707,160
-23% -$230M 0.09% 197
2024
Q1 		$1.03B Sell
3,101,049
-214,416
-6% -$65.5M 0.13% 162
2023
Q4 		$897M Buy
3,315,465
+188,377
+6% +$46.6M 0.12% 166
2023
Q3 		$769M Sell
3,127,088
-2,619,322
-46% -$717M 0.11% 183
2023
Q2 		$1.74B Sell
5,746,410
-2,227,614
-28% -$619M 0.24% 77
2023
Q1 		$2.1B Buy
7,974,024
+934,406
+13% +$237M 0.31% 63
2022
Q4 		$1.69B Buy
7,039,618
+1,734,194
+33% +$388M 0.27% 82
2022
Q3 		$975M Buy
5,305,424
+354,202
+7% +$70.6M 0.16% 130
2022
Q2 		$832M Sell
4,951,222
-10,123,663
-67% -$2.17B 0.11% 203
2022
Q1 		$3.78B Sell
15,074,885
-6,054,049
-29% -$1.52B 0.38% 45
2021
Q4 		$5.43B Sell
21,128,934
-257,102
-1% -$62.9M 0.49% 30
2021
Q3 		$5.19B Sell
21,386,036
-566,566
-3% -$139M 0.49% 33
2021
Q2 		$4.54B Sell
21,952,602
-1,521,734
-6% -$310M 0.42% 39
2021
Q1 		$4.42B Sell
23,474,336
-1,686,405
-7% -$297M 0.44% 35
2020
Q4 		$4.14B Buy
25,160,741
+2,231,318
+10% +$326M 0.42% 43
2020
Q3 		$2.86B Buy
22,929,423
+424,576
+2% +$52.6M 0.33% 57
2020
Q2 		$2.18B Sell
22,504,847
-221,985
-1% -$23.1M 0.27% 73
2020
Q1 		$2.04B Buy
22,726,832
+2,605,622
+13% +$337M 0.32% 62
2019
Q4 		$2.97B Buy
20,121,210
+2,574,337
+15% +$346M 0.39% 52
2019
Q3 		$2.11B Buy
17,546,873
+1,640,734
+10% +$212M 0.3% 75
2019
Q2 		$2.15B Buy
15,906,139
+1,375,021
+9% +$174M 0.3% 75
2019
Q1 		$1.89B Buy
14,531,118
+1,573,152
+12% +$211M 0.28% 83
2018
Q4 		$1.61B Buy
12,957,966
+2,154,233
+20% +$289M 0.27% 89
2018
Q3 		$1.5B Buy
10,803,733
+1,403,737
+15% +$175M 0.22% 108
2018
Q2 		$964M Buy
9,399,996
+1,846,367
+24% +$187M 0.15% 151
2018
Q1 		$733M Buy
7,553,629
+2,342,060
+45% +$227M 0.12% 192
2017
Q4 		$458M Sell
5,211,569
-12,685,577
-71% -$1.02B 0.07% 274
2017
Q3 		$1.42B Sell
17,897,146
-322,952
-2% -$26M 0.24% 98
2017
Q2 		$1.59B Buy
18,220,098
+4,314,218
+31% +$365M 0.29% 85
2017
Q1 		$1.24B Buy
13,905,880
+5,617,718
+68% +$468M 0.23% 110
2016
Q4 		$613M Sell
8,288,162
-2,745,850
-25% -$206M 0.12% 195
2016
Q3 		$835M Sell
11,034,012
-1,155,143
-9% -$88.4M 0.17% 145
2016
Q2 		$939M Sell
12,189,155
-1,179,921
-9% -$93.1M 0.2% 128
2016
Q1 		$1.04B Sell
13,369,076
-841,762
-6% -$58.8M 0.22% 116
2015
Q4 		$961M Buy
14,210,838
+1,908,768
+16% +$133M 0.2% 126
2015
Q3 		$952M Buy
12,302,070
+388,814
+3% +$34.4M 0.21% 110
2015
Q2 		$1.08B Buy
11,913,256
+995,014
+9% +$79.7M 0.22% 113
2015
Q1 		$821M Buy
10,918,242
+273,837
+3% +$19.7M 0.17% 153
2014
Q4 		$781M Buy
10,644,405
+2,411,206
+29% +$169M 0.17% 156
2014
Q3 		$581M Buy
8,233,199
+2,709,071
+49% +$179M 0.13% 191
2014
Q2 		$311M Sell
5,524,128
-794,306
-13% -$41.9M 0.07% 331
2014
Q1 		$332M Sell
6,318,434
-445,503
-7% -$22.2M 0.07% 313
2013
Q4 		$323M Sell
6,763,937
-309,610
-4% -$14.3M 0.07% 309
2013
Q3 		$302M Sell
7,073,547
-296,802
-4% -$11.6M 0.08% 302
2013
Q2 		$266M Buy
+7,370,349
New +$285M 0.07% 321

Other funds holding HCA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates's HCA Position: Q1 2026 in Review

T. Rowe Price Associates reduced its HCA Healthcare (HCA) stake by 7.3% in Q1 2026, selling an estimated $20.8M and leaving 520,317 shares worth $246M. The position accounts for 0.03% of the portfolio, ranked #409.

T. Rowe Price Associates first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.43B in Q4 2021. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • T. Rowe Price Associates held 520,317 shares of HCA Healthcare worth $246M as of Q1 2026.
  • T. Rowe Price Associates sold 41,273 HCA Healthcare shares in Q1 2026, an estimated $20.8M.
  • HCA Healthcare made up 0.03% of T. Rowe Price Associates's portfolio in Q1 2026, its #409 holding.
  • T. Rowe Price Associates first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's HCA Healthcare position peaked at $5.43B in Q4 2021.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.